Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03687502 · ClinicalTrials.gov registry record · Phase 2

The Role of Contrast Enhanced Ultrasound in Appendicitis

A Phase 2 study of Acute Appendicitis, sponsored by Children's Mercy Hospital Kansas City.

Completed
Registry status
Phase 2
Development phase
37
Enrollment target
1
Study location

NCT03687502 is a Phase 2 study of Acute Appendicitis that has completed, run by Children's Mercy Hospital Kansas City. The registered enrollment target is 37 participants, below the 884-participant average among 4 other Acute Appendicitis trials with a reported enrollment target (96% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03687502, a Phase 2 study of Acute Appendicitis, has completed, sponsored by Children's Mercy Hospital Kansas City.

COMPLETED
Registry status
Phase 2
Development phase
37 participants
Enrollment target
1
Study location

Study Summary

This study seeks to determine the efficacy of Contrast Enhanced Ultrasound (CEUS) in improving the diagnosis of acute appendicitis in children, when compared to the standard grey-scale ultrasound.

Conditions Studied

Interventions

  • DRUG Sulfur hexafluoride lipid-type A microspheres

Study Locations (1)

Missouri

  • Children's Mercy Kansas City - Kansas City

Trial Details

FieldValue
Enrollment Target 37 participants
Start Date 2019-01-04
Est. Completion 2022-07-05
Phase Phase 2

What the Registry Record Tells You About NCT03687502

The ClinicalTrials.gov registry entry for NCT03687502 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 37 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 884-participant average among 4 other Acute Appendicitis trials with a reported enrollment target (96% lower). The listed sponsor is Children's Mercy Hospital Kansas City, which has 184 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Acute Appendicitis appearing as the primary indexed condition, and to 1 intervention - of which Sulfur hexafluoride lipid-type A microspheres is the first listed.

NCT03687502 reports 1 study location spanning 1 distinct geographic area - top geographies include Missouri.

Frequently Asked Questions

What is clinical trial NCT03687502 about?

NCT03687502 is a clinical study titled "The Role of Contrast Enhanced Ultrasound in Appendicitis". This study seeks to determine the efficacy of Contrast Enhanced Ultrasound (CEUS) in improving the diagnosis of acute appendicitis in children, when compared to the standard grey-scale ultrasound.

What is the current status of trial NCT03687502?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 37 participants. The study started on 2019-01-04. Estimated completion is 2022-07-05.

What conditions does trial NCT03687502 study?

This clinical trial studies the following conditions: Acute Appendicitis.

What interventions are being tested in trial NCT03687502?

The interventions under investigation include: Sulfur hexafluoride lipid-type A microspheres (DRUG).

Who is sponsoring clinical trial NCT03687502?

This trial is sponsored by Children's Mercy Hospital Kansas City, which has 184 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03687502 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Acute Appendicitis

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.